Breakingviews - Corona Capital: Vaccines, Olive Garden, Oil [Reuters]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Reuters
Breakingviews - Corona Capital: Vaccines, Olive Garden, Oil By Breakingviews columnists 9 Min Read LONDON/NEW YORK/MILAN/HONG KONG (Reuters Breakingviews) - Corona Capital is a daily column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights. - Vaccine nervousness - Darden’s beat - Oil’s straight talking JAB JOB. Pharmaceutical companies like Johnson & Johnson and Moderna are racing to make Covid-19 vaccines – but the real holdup may be Americans themselves. Less than 40% say they’re likely, or somewhat likely, to sign up for the first-generation vaccine, according to a recent Axios-Ipsos Coronavirus Index, with around a fifth saying they’d wait at least a year. They’re also balking at paying: A third say they plan to pay nothing out of pocket for the jab. This is bad news for everyone, not just Big Pharma. Fully opening schools, offices, restaurants – indeed, the economy itself – relies, in large part, on people taking
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- With Lawsuit And Medtech Tailwinds - Johnson & Johnson May Be Back [Seeking Alpha]Seeking Alpha
- Manifest Technologies Emerges From Stealth With Strategic Investors and Prepares for Next Development Stage of AI-Powered Precision Neuroscience [Yahoo! Finance]Yahoo! Finance
- The Road To A Decentralized Work Life [Forbes]Forbes
- Global Bariatric Surgery Market Analysis Report 2024-2033: Addressing Obesity's Impact Extending Beyond Weight Concerns [Yahoo! Finance]Yahoo! Finance
- J&J can contest evidence linking its talc to cancer, judge rules [CNBC]CNBC
JNJ
Earnings
- 1/23/24 - Beat
JNJ
Sec Filings
- 3/27/24 - Form PX14A6G
- 3/13/24 - Form 4
- 3/13/24 - Form 144
- JNJ's page on the SEC website